Provided by Tiger Fintech (Singapore) Pte. Ltd.

Virtus LifeSci Biotech Clinical Trials ETF

19.74
-0.0700-0.35%
Post-market: 19.740.00000.00%16:04 EDT
Volume:45.91K
Turnover:898.83K
Market Cap:10.86M
PE:- -
High:19.74
Open:19.70
Low:19.44
Close:19.81
Loading ...

Company Profile

Company Name:
Virtus LifeSci Biotech Clinical Trials ETF
Exchange:
NASDAQ
Establishment Date:
2014
Employees:
- -
Office Location:
One Financial Plaza,Hartford,Connecticut,United States
Website:
- -
Zip Code:
06103
Fax:
(860) 241-1024
Introduction:
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.